Yongyan Wu

3.2k total citations
78 papers, 2.0k citations indexed

About

Yongyan Wu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yongyan Wu has authored 78 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 33 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Yongyan Wu's work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (19 papers) and Pluripotent Stem Cells Research (17 papers). Yongyan Wu is often cited by papers focused on MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (19 papers) and Pluripotent Stem Cells Research (17 papers). Yongyan Wu collaborates with scholars based in China, Tunisia and Australia. Yongyan Wu's co-authors include Wei Gao, Zekun Guo, Yong Zhang, Xiwang Zheng, Shuxin Wen, Zhiying Ai, Yujia Guo, Changming An, Yuliang Zhang and Xiaoyan Shi and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yongyan Wu

76 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongyan Wu China 28 1.5k 729 229 183 175 78 2.0k
Dawne N. Shelton United States 19 961 0.7× 392 0.5× 262 1.1× 339 1.9× 126 0.7× 36 1.7k
Anabella Srebrow Argentina 23 1.6k 1.1× 362 0.5× 244 1.1× 163 0.9× 116 0.7× 32 2.0k
Zheng Hu China 24 1.1k 0.7× 390 0.5× 319 1.4× 161 0.9× 213 1.2× 83 1.7k
Jungho Kim South Korea 20 1.2k 0.8× 349 0.5× 189 0.8× 73 0.4× 217 1.2× 54 1.6k
Wufang Fan China 18 1.1k 0.8× 312 0.4× 402 1.8× 187 1.0× 182 1.0× 28 1.6k
Yuan Chao Xue Canada 21 1.3k 0.9× 475 0.7× 139 0.6× 161 0.9× 191 1.1× 41 1.9k
Takanori Eguchi Japan 31 2.1k 1.5× 923 1.3× 413 1.8× 260 1.4× 136 0.8× 79 2.8k

Countries citing papers authored by Yongyan Wu

Since Specialization
Citations

This map shows the geographic impact of Yongyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongyan Wu more than expected).

Fields of papers citing papers by Yongyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongyan Wu. The network helps show where Yongyan Wu may publish in the future.

Co-authorship network of co-authors of Yongyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongyan Wu. A scholar is included among the top collaborators of Yongyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongyan Wu. Yongyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Chengyi, et al.. (2025). Land and water resource effects of power structure transformation in China: Telecoupling and spatial redistribution. Journal of Environmental Management. 394. 127347–127347. 2 indexed citations
3.
Yan, Shiqiang, Wanglai Hu, Ziwen Li, et al.. (2024). Biomechanical research using advanced micro-nano devices: In-Vitro cell Characterization focus. Journal of Advanced Research. 76. 615–637. 1 indexed citations
4.
Zheng, Xiwang, Chunming Zhang, Huina Guo, et al.. (2023). A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma. Frontiers in Oncology. 13. 1055717–1055717. 1 indexed citations
5.
Zhang, Yu, Li Li, Ji‐Min Cao, et al.. (2021). Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?. Molecular Therapy — Oncolytics. 20. 240–264. 54 indexed citations
6.
Zhang, Chunming, Xuting Xue, Shuxin Wen, et al.. (2021). Alterations of bacterial communities of vocal cord mucous membrane increases the risk for glottic laryngeal squamous cell carcinoma. Journal of Cancer. 12(13). 4049–4063. 12 indexed citations
7.
Zheng, Xiwang, et al.. (2021). Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma. Molecular Therapy — Oncolytics. 20. 342–351. 52 indexed citations
8.
Wu, Yongyan, Xiaojuan Zhao, Yujia Guo, et al.. (2020). Petroleum extract of Farfarae Flos alleviates nasal symptoms by regulating the Th1-Th2 cytokine balance in a mouse model of Allergic Rhinitis. International Journal of Medical Sciences. 18(2). 555–563. 6 indexed citations
9.
Feng, Yuchen, Xiao Ying Liu, Teng Liu, et al.. (2020). c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis. Nature Communications. 11(1). 4980–4980. 79 indexed citations
10.
Wang, Jue, Jiamin Fan, Wei Gao, et al.. (2020). LY6D as a Chemoresistance Marker Gene and Therapeutic Target for Laryngeal Squamous Cell Carcinoma. Stem Cells and Development. 29(12). 774–785. 20 indexed citations
11.
Song, Kun, Qian Li, Wei Gao, et al.. (2019). AlloDriver: a method for the identification and analysis of cancer driver targets. Nucleic Acids Research. 47(W1). W315–W321. 34 indexed citations
12.
Cui, Jiajia, Yuliang Zhang, Min Niu, et al.. (2019). Mass spectrometry‐based proteomic analysis of FSCN1‐interacting proteins in laryngeal squamous cell carcinoma cells. IUBMB Life. 71(11). 1771–1784. 17 indexed citations
13.
Shi, Yong, Yujia Guo, Shuxin Wen, et al.. (2019). Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review. Journal of Cancer. 10(19). 4455–4462. 53 indexed citations
15.
Wang, Yanqin, Huiyun Chang, Yongyan Wu, et al.. (2016). Inability of FMDV replication in equine kidney epithelial cells is independent of integrin αvβ3 and αvβ6. Virology. 492. 251–258. 7 indexed citations
16.
Liu, Junping, et al.. (2013). Developmental Potential of Cloned Goat Embryos from an SSEA3 + Subpopulation of Skin Fibroblasts. Cellular Reprogramming. 15(2). 159–165. 6 indexed citations
17.
Liu, Jun, Yongsheng Wang, Jianmin Su, et al.. (2013). Effect of the Time Interval Between Fusion and Activation on Epigenetic Reprogramming and Development of Bovine Somatic Cell Nuclear Transfer Embryos. Cellular Reprogramming. 15(2). 134–142. 5 indexed citations
18.
Shi, Xiaoyan, Yongyan Wu, Zhiying Ai, et al.. (2013). AICAR Sustains J1 Mouse Embryonic Stem Cell Self-Renewal and Pluripotency by Regulating Transcription Factor and Epigenetic Modulator Expression. Cellular Physiology and Biochemistry. 32(2). 459–475. 16 indexed citations
19.
Peng, Hui, Yongyan Wu, & Yong Zhang. (2012). Efficient Delivery of DNA and Morpholinos into Mouse Preimplantation Embryos by Electroporation. PLoS ONE. 7(8). e43748–e43748. 39 indexed citations
20.
Su, Jianmin, Yongsheng Wang, Yanyan Li, et al.. (2011). Oxamflatin Significantly Improves Nuclear Reprogramming, Blastocyst Quality, and In Vitro Development of Bovine SCNT Embryos. PLoS ONE. 6(8). e23805–e23805. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026